Not a conference agenda. A sequence of decisions.
5 October 2026. Every segment ends in a question put directly to the room, not a keynote.
Afternoon Session
BKC, Mumbai, India
Founding Dinner
Indian Accent, Jio World Centre, BKC
Phase 01
Afternoon Working Session
BKC, Mumbai, India (14:00 – 16:30)
14:00 – 14:30
Closed-Door Briefing
Framing the Capital Gap & Legal Precedent
Presentation of macro bioeconomy capital contraction ($195.3B deficit) and SEBI REIT/InvIT precedent models for ring-fencing intangible assets.
14:30 – 15:30
Architecture & AI
Scientific Asset Receipts (SARs) & AI Underwriting
Deep-dive technical walkthrough of trustee-held SPV structures, bankruptcy-remoteness, and continuous probability pricing driven by the 3-layer AI engine.
15:30 – 16:30
Syndicate Workshop
Founding Syndicate Formation & Target Pipeline
Closed deliberation among the 40 principals to define initial asset selection criteria and structure the inaugural Q1 2027 capital issuance pool.
Phase 02
Founding Dinner & Reception
Indian Accent, Jio World Centre (19:00 – 22:30)
19:00 – 19:45
Private Reception
Cocktails & Delegate Assembly
High-level networking cocktail reception for confirmed delegates, sovereign allocators, and keynotes in the private dining suite.
20:00 – 21:15
Culinary Keynotes
Founding Dinner & Strategic Statements
Curated multi-course culinary experience paired with short keynotes from biopharma CEOs, family office heads, and regulatory advisors.
21:15 – 22:30
Synthesis
Closing Communique & Singapore Corridor
Finalization of the Mumbai table communique and announcement of the TOKEN2049 Singapore global network launch parameters.
BY INVITATION ONLY
Request a Seat at The Scientific Capital Table
Participation is strictly limited to 40 primary decision-makers across Sovereign Funds, Family Offices, Biopharma CEOs, Market Intermediaries, and Policy Leaders.
